Dishman Carbogen Amcis Quarterly Results for Trading Insights
DCAL • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹65 Cr
QSept 2025
Dishman Carbogen Amcis Quarterly Results Key Highlights
- Revenue of ₹661 Cr in Sept 2025 (-8.7% vs Mar 2025, -17.0% vs Sept 2024)
- Net Profit of ₹65 Cr in Sept 2025 (+51.2% vs Mar 2025, +97.0% vs Sept 2024)
- EBITDA of ₹157 Cr in Sept 2025 (+5.4% vs Mar 2025)
- Operating Margin of 23.0% in Sept 2025 (+3.0pp vs Mar 2025)
- Earnings Per Share of ₹4.16 in Sept 2025 (+51.3% vs Mar 2025)
Dishman Carbogen Amcis Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 661 | 724 | 733 | 796 | 662 | -8.7% | -17.0% |
| Net Profit (₹ Cr) | 65 | 43 | 23 | 33 | -70 | - | - |
| EBITDA (₹ Cr) | 157 | 149 | 163 | 151 | 67 | - | - |
| EPS (₹) | 4.16 | 2.75 | 1.49 | 2.11 | -4.46 | - | - |
| Operating Margin (%) | 23.0% | 20.0% | 19.0% | 18.0% | 9.0% | - | - |
Dishman Carbogen Amcis Share Price Trend Around Quarterly Results
Visualize Dishman Carbogen Amcis's 1-year price movement across quarterly results — ideal for logging trades in Dishman Carbogen Amcis share price
chart using Tickjournal. All values in ₹.
Related Pages for Dishman Carbogen Amcis
Additional stock information and data for DCAL
Revenue Trend (₹ Cr)
Sept 2024
796
Jun 2025
733
Mar 2025
724
Sept 2025
661
Net Profit Trend (₹ Cr)
Sept 2024
33
Jun 2025
23
Mar 2025
43
Sept 2025
65
Operating Margin Trend (%)
Sept 2024
18.0%
Jun 2025
19.0%
Mar 2025
20.0%
Sept 2025
23.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Dishman Carbogen Amcis quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹412,613.60 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹169,700.80 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹129,171.09 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,570.84 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores